These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 8688259)
1. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. De Wolf AM; Freeman JA; Scott VL; Tullock W; Smith DA; Kisor DF; Kerls S; Cook DR Br J Anaesth; 1996 May; 76(5):624-8. PubMed ID: 8688259 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients. Smith CE; van Miert MM; Parker CJ; Hunter JM Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Ornstein E; Lien CA; Matteo RS; Ostapkovich ND; Diaz J; Wolf KB Anesthesiology; 1996 Mar; 84(3):520-5. PubMed ID: 8659778 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Cook DR; Freeman JA; Lai AA; Kang Y; Stiller RL; Aggarwal S; Harrelson JC; Welch RM; Samara B Br J Anaesth; 1992 Dec; 69(6):580-5. PubMed ID: 1334687 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure. Cook DR; Freeman JA; Lai AA; Robertson KA; Kang Y; Stiller RL; Aggarwal S; Abou-Donia MM; Welch RM Anesth Analg; 1991 Feb; 72(2):145-50. PubMed ID: 1824669 [TBL] [Abstract][Full Text] [Related]
9. Newer neuromuscular blocking agents: how do they compare with established agents? Sparr HJ; Beaufort TM; Fuchs-Buder T Drugs; 2001; 61(7):919-42. PubMed ID: 11434449 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation. Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Sorooshian SS; Stafford MA; Eastwood NB; Boyd AH; Hull CJ; Wright PM Anesthesiology; 1996 May; 84(5):1083-91. PubMed ID: 8624002 [TBL] [Abstract][Full Text] [Related]
13. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium]. Savarese JJ; Lien CA; Belmont MR; Wastila WB Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of cisatracurium after a short infusion in patients under propofol anesthesia. Tran TV; Fiset P; Varin F Anesth Analg; 1998 Nov; 87(5):1158-63. PubMed ID: 9806701 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Atherton DP; Hunter JM Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Fahey MR; Rupp SM; Fisher DM; Miller RD; Sharma M; Canfell C; Castagnoli K; Hennis PJ Anesthesiology; 1984 Dec; 61(6):699-702. PubMed ID: 6239574 [TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363 [TBL] [Abstract][Full Text] [Related]
18. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Richard A; Girard F; Girard DC; Boudreault D; Chouinard P; Moumdjian R; Bouthilier A; Ruel M; Couture J; Varin F Anesth Analg; 2005 Feb; 100(2):538-544. PubMed ID: 15673889 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198 [TBL] [Abstract][Full Text] [Related]
20. Dose requirements and recovery profile of an infusion of cisatracurium during liver transplantation. Cammu G; Bossuyt G; De Baerdemaeker L; Den Blauwen N; Struys M; Mortier E J Clin Anesth; 2002 Mar; 14(2):135-9. PubMed ID: 11943528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]